Latest Legal Proceedings News

Anax Metals has mutually withdrawn its arbitration against a cornerstone investor over exclusive marketing rights, keeping its convertible notes valid and avoiding immediate financial disruption.

Green Critical Minerals has released a robust Pre-Feasibility Study for the McIntosh Graphite Project, highlighting significant economic potential and a long mine life. Meanwhile, NH3 Clean Energy advances its flagship WAH2 ammonia project towards key development milestones.

The Star Entertainment Group is asking shareholders to approve a $400 million strategic investment package critical to its survival, involving convertible notes from Bally's and its largest shareholder. This move aims to secure the company’s future amid ongoing legal challenges and financial strain.

Dexus reports a slight 0.4% increase in portfolio valuations driven by rental growth, alongside an 18-cent estimated distribution. Meanwhile, legal proceedings involving its APAC stake face delays, clouding future outcomes.

Renergen Limited reports steady LNG production despite maintenance downtime, progresses a strategic merger with ASP Isotopes, and advances exploration with new seismic data and drilling activity.

Dubber Corporation has initiated court proceedings against its former auditors following a $26.6 million misappropriation uncovered in FY24, aiming to restore financial stability by year-end.

Silk Logistics Holdings has announced a court-ordered postponement of the Scheme Meeting for its acquisition by DP World Australia, delaying shareholder decisions and the acquisition timeline.

Bathurst Resources reports robust cash reserves and steady profitability while progressing development of its Buller and Tenas metallurgical coal projects. The company also navigates ongoing litigation that could impact its governance.

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Mayne Pharma has dismissed a fresh termination notice from Cosette Pharmaceuticals, reaffirming its commitment to proceed with the upcoming Scheme Meeting on 18 June 2025. The dispute centers on the validity of the Scheme Implementation Deed termination claims.

Yowie Group Ltd has initiated an off-market takeover bid to acquire Keybridge Capital Limited, offering one Yowie share for each Keybridge share amid Keybridge's financial distress and administration history.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.